Bullish option traders have turned fast profits in the SPDR S&P Biotech Fund ($XBI). On Nov. 17, Market Rebellion’s Unusual Option Activity Service found that 2,750
Bullish option traders have turned large gains in the SPDR S&P Biotech Fund ($XBI). On Mar. 24, Market Rebellion’s Unusual Option Activity Service found that 8,400
Bullish option traders have turned large profits in the SPDR S&P Biotech Fund ($XBI) in just a matter of days. On Jul. 26, Market Rebellion’s Unusual
Bullish option traders have turned large profits in the SPDR S&P Biotech Fund ($XBI) in just a matter of days. On Oct. 28, Market Rebellion’s Unusual Activity
Bullish option traders logged exponential gains in the SPDR S&P Biotech Fund today. On Feb. 15, Investitute’s tracking systems showed that 2,500 Weekly $88 calls
On today’s CNBC Halftime Report, Pete Najarian is seeing unusual option activity in $XLE, $XBI and $MRK. Pete sees unusual activity in XLE, as traders purchased
The SPDR S&P Biotech Fund has seen its share price plunge by more than a third in the last four months, handing major profits to
Option traders posted gains on bearish positions in the SPDR S&P Biotech Fund today for the third time this month. On Oct. 24, Investitute’s tracking
Bearish option traders have turned large profits in the SPDR S&P Biotech Fund. On Oct. 2, Investitute’s market scanners identified the purchase of 5,000 November
Downside option traders have doubled their money in the SPDR S&P Biotech Fund. On Sept. 12, Investitute’s tracking systems showed that 9,000 October $95 puts
It took less than a week for bears to double their money in the SPDR S&P Biotech Fund. On March 13, Investitute’s proprietary programs flagged
